MENU
+Compare
FHLC
ETF ticker: NYSE ARCA
AS OF
Dec 18, 11:35 AM (EDT)
Price
$66.71
Change
+$0.30 (+0.45%)
Net Assets
2.68B

FHLC stock forecast, quote, news & analysis

Category: @Health
FHLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FHLC with price predictions
Dec 17, 2024

Momentum Indicator for FHLC turns negative, indicating new downward trend

FHLC saw its Momentum Indicator move below the 0 level on December 10, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In of the 86 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FHLC turned negative on December 11, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHLC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FHLC entered a downward trend on November 25, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FHLC advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

FHLC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.

Market Cap

The average market capitalization across the Fidelity MSCI Health Care ETF ETF is 18.62B. The market cap for tickers in the group ranges from 29.4M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is RAPT at 29.4M.

High and low price notable news

The average weekly price growth across all stocks in the Fidelity MSCI Health Care ETF ETF was 25%. For the same ETF, the average monthly price growth was 109%, and the average quarterly price growth was 410%. PDCO experienced the highest price growth at 34%, while KROS experienced the biggest fall at -73%.

Volume

The average weekly volume growth across all stocks in the Fidelity MSCI Health Care ETF ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was -29% and the average quarterly volume growth was 23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 72
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 75
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
FHLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
82 Devonshire StreetBoston
Phone
N/A
Web
www.institutional.fidelity.com